MIRA INFORM REPORT
|
Report
Date : |
06.02.2007 |
IDENTIFICATION
DETAILS
|
Name : |
SUYOG DIAGNOSTICS PRIVATE LIMITED |
|
|
|
|
Formerly
Known As : |
SUYOG
SALES AGENCY PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Stadium House, Block No. 1, 6th Floor, Veer
Nariman Road, Churchgate, Mumbai- 400 020, Maharashtra |
|
|
|
|
Country
: |
India |
|
|
|
|
Financials
(as on) : |
31.03.2006 |
|
|
|
|
Date
of Incorporation : |
25.07.1991 |
|
|
|
|
Com.
Reg. No.: |
11-62661 |
|
|
|
|
CIN
No.: [Company
Identification No.] |
U51109MH1991PTC062661 |
|
|
|
|
TAN
No.: [Tax
Deduction & Collection Account No.] |
MUMS37228C |
|
|
|
|
PAN
No.: [Permanent
Account No.] |
AAACS7262 |
|
|
|
|
Legal
Form : |
Private Limited Liability Company |
|
|
|
|
Line
of Business : |
Marketers of Diagnostic Kits, Reagents and Instruments |
RATING & COMMENTS
|
MIRA’s
Rating : |
Ba |
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal.
Capable to meet normal commitments. |
Satisfactory |
|
Maximum
Credit Limit : |
USD 50000 |
|
|
|
|
Status
: |
Satisfactory
|
|
|
|
|
Payment
Behaviour : |
Usually
correct |
|
|
|
|
Litigation
: |
Clear |
|
|
|
|
Comments
: |
Subject is a well established company having satisfactory
track records. Trade relations are fair. Financial position is
satisfactory. Payments are usually
correct and as per commitments. Nothing adverse reported. The company can be considered normal for business dealings
at usual trade terms and conditions. |
LOCATIONS
|
Registered
Office : |
Stadium House, Block No. 1, 6th Floor, Veer
Nariman Road, Churchgate, Mumbai- 400 020, Maharashtra, India |
|
Tel.
No.: |
91-22-22856003 |
|
Fax
No.: |
91-22-22382584
/ 22882586 |
|
E-Mail
: |
|
|
Website
: |
|
|
|
|
|
Corporate
Office : |
Noble
House, F-315, Old M. B. Road, Lado Salai, New Delhi - 400 030, India |
|
|
|
|
Warehouse
: |
Located
at : Andheri,
Mumbai, Maharashtra |
DIRECTORS
|
Name : |
Mr. Mahendra Prasad Jain |
|
Designation
: |
Whole Time Director |
|
Address
: |
S-287, Panchsheel Park, New Delhi - 110 017,
India |
|
Date
of Birth/Age : |
24/03/1934 |
|
Date
of Appointment : |
01/11/1996 |
|
|
|
|
Name : |
Mr. Surendra Keshavdeo Ruia |
|
Designation
: |
Wholetime Director |
|
Address
: |
75 Ruia House, Juhu Lane, Andheri (West) Mumbai -
400058, Maharashtra, India |
|
Date
of Birth/Age : |
25/11/1946 |
|
Date
of Appointment : |
25/07/1991 |
|
|
|
|
Name : |
Mr.
Rajesh Maheshwari |
|
Designation
: |
Director |
|
Address
: |
3162, Sitaram
Bazar, Delhi- 400006, India |
|
Date
of Birth/Age : |
21/09/1964 |
|
Date
of Appointment : |
15/03/1999 |
|
|
|
|
Name : |
Mr. Sumaj
Mahendra Jain |
|
Designation
: |
Director |
|
Address
: |
S-287, Panchsheel Park, New Delhi - 110 017,
India |
|
Date
of Birth/Age : |
17/12/1964 |
|
Date
of Appointment : |
08/04/2004 |
MAJOR SHAREHOLDERS
|
Names of Shareholders |
No of Shares |
|
Mrs.
Shashikala Ruia |
6,050 |
|
Surendra
Ruia |
14,712 |
|
Mrs.
Shanti Ruia |
3,000 |
|
Kendall Premium
Healthcare Products Limited |
8,000 |
|
Premier
Travel Limited |
2,400 |
|
Sonar
Paper Products Private Limited |
1,000 |
|
Dr. M. P.
Jain |
2,000 |
|
Mrs.
Sudha Jain |
1,500 |
|
Sumaj
Jain |
1,547 |
|
Ms. Parul
Jain |
3,000 |
|
Ms. Era
Jain |
3,000 |
|
Mr.
Mahesh Sekseria |
1 |
|
Mrs.
Shammi Nagpal |
1 |
|
Mr.
Yogendra Shah |
1 |
|
Ms.
Nikita Ruia |
50 |
|
Keshavdeo
S. Ruia – HUF |
50 |
|
TOTAL |
46,312 |
BUSINESS DETAILS
|
Line
of Business : |
Marketers of Diagnostic Kits, Reagents and Instruments |
GENERAL INFORMATION
|
No. of
Employees : |
60 |
|
|
|
|
Bankers
: |
|
|
|
|
|
Banking Relations : |
Satisfactory |
|
|
|
|
Auditors
: |
Dinesh
Tibarewala & Associates Chartered
Accountants C-210,
Sahakar Apartments, S. V. Road, Malad [West], Mumbai – 400084, Maharashtra,
India |
|
|
|
|
Associates/Subsidiaries
: |
Nil |
CAPITAL STRUCTURE
Authorised
Capital :
|
No. of
Shares |
Type |
Value |
Amount |
|
100,000 |
Equity Shares |
Rs. 100/- each |
Rs. 10.000 millions |
Issued,
Subscribed & Paid-up Capital :
|
No. of
Shares |
Type |
Value |
Amount |
|
46,312 |
Equity Shares |
Rs. 100/- each |
Rs. 4.631 millions |
FINANCIAL DATA
[all figures are in Rupees Millions]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2006 |
31.03.2005 |
31.03.2004 |
|
|
SHAREHOLDERS
FUNDS |
|
|
|
|
|
1] Share
Capital |
4.631 |
4.631 |
9.965 |
|
|
2] Share
Application Money |
5.334 |
5.334 |
0.000 |
|
|
3]
Reserves & Surplus |
1.960 |
1.778 |
0.000 |
|
|
4]
(Accumulated Losses) |
0.000 |
0.000 |
[0.226] |
|
NETWORTH
|
11.925 |
11.743 |
9.739 |
|
|
LOAN
FUNDS |
|
|
|
|
|
1]
Secured Loans |
14.381 |
12.710 |
10.124 |
|
|
2]
Unsecured Loans |
6.583 |
7.339 |
8.566 |
|
TOTAL
BORROWING
|
20.964 |
20.049 |
18.690 |
|
|
DEFERRED
TAX LIABILITIES |
0.236 |
0.450 |
0.485 |
|
|
|
|
|
|
|
TOTAL
|
33.125 |
32.242 |
28.914 |
|
|
|
|
|
|
|
APPLICATION OF FUNDS
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block]
|
13.589 |
11.211 |
10.667 |
|
Capital work-in-progress
|
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
INVESTMENT
|
0.000 |
0.000 |
0.000 |
|
DEFERREX TAX ASSETS
|
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES
|
|
|
|
|
|
|
Inventories
|
10.028
|
9.929 |
14.052 |
|
|
Sundry Debtors
|
41.144
|
36.188 |
22.005 |
|
|
Cash & Bank Balances
|
1.961
|
0.755 |
[0.111] |
|
|
Other Current Assets
|
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances
|
1.432
|
0.294 |
1.650 |
Total Current Assets
|
54.565
|
47.166 |
37.596 |
|
Less : CURRENT LIABILITIES & PROVISIONS
|
|
|
|
|
|
|
Current Liabilities
|
31.942
|
22.914 |
19.368 |
|
|
Provisions
|
3.097
|
3.236 |
|
Total Current Liabilities
|
35.039
|
26.150 |
19.368 |
|
Net
Current Assets
|
19.526
|
21.016 |
18.228 |
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES
|
0.010 |
0.015 |
0.019 |
|
|
|
|
|
|
|
TOTAL
|
33.125 |
32.242 |
28.914 |
|
PROFIT & LOSS ACCOUNT
|
PARTICULARS |
|
|
31.03.2004 |
Sales Turnover [including other income]
|
|
|
81.302 |
|
|
|
|
|
Profit/(Loss) Before Tax
|
|
|
1.312 |
Provision for Taxation
|
|
|
0.590 |
Profit/(Loss) After Tax
|
|
|
0.722 |
|
|
|
|
|
Import Value
|
|
|
42.999 |
|
|
|
|
|
Total Expenditure
|
|
|
52.039 |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2006 |
31.03.2005 |
31.03.2004 |
PAT / Total Income
|
(%)
|
NA
|
NA |
0.89 |
|
|
|
|
|
|
Net Profit Margin
(PBT/Sales) |
(%) |
NA
|
NA |
1.61 |
|
|
|
|
|
|
Return on Total Assets
(PBT/Total
Assets} |
(%) |
NA
|
NA |
2.72 |
|
|
|
|
|
|
Return on Investment (ROI)
(PBT/Networth) |
|
NA
|
NA |
0.13 |
|
|
|
|
|
|
Debt Equity Ratio
(Total
Liability/Networth) |
|
4.70
|
3.93 |
3.91 |
|
|
|
|
|
|
Current Ratio
(Current
Asset/Current Liability) |
|
1.56
|
1.80 |
1.94 |
LOCAL AGENCY FURTHER INFORMATION
Fixed Assets
- Furniture and Fixture
- Office Equipments
- Vehicles
- Air Conditioner
- Computer
- Pager
- Deep Freezer
- Xerox Machine
The company
acts as marketers of diagnostic kits, reagents and instruments.
Generic
Names of Principal Products/Services are :
- Diagnostic Kits &
Instruments
- Diagnastic Reagents Kits
Medical Electronics Instruments
The
company is engaged in marketing of Diagnostics Kits, Reagents &
Instruments, which are used in Hospitals, Laboratories and Blood Banks. The
company has entered into marketing arrangments with Diagnostic Stago- France
from their Awemostasis products and instruments with Organies Limited Isreal
for rapid Elisa Kits. The company now
has a complete range of diagnastic products in all price ranges. The company
now has all India Sales Network comprising of 40 dedicated diagnostic
specialists. It also has 45 distributors all over the country and the cold
storage facilities for the products is maintained at all the centrers with main
warehouse at Delhi and Mumbai.
Director’s Report:
The company has entered into distribution arrangements with
:
M/s. Agdia Incorporated – USA for selling of Plant Pathogent Kits and providing specialized testing
facility for diagueseas of different plant virus by elisa and Pcr Techniques.
M/s. Compumed-USA for instruments and software for
measurement of Bone Densitometry.
M/s. Genelabs Diagnostic Pte. Limited - Singapore
a leading diagnostic of dealing in confirmatory test of HIV and HCV,
they also manufacture Dengu, HEV and Other Diagnostics Kits, Reagents and
Instruments.
The company has now a complete range of diagnostic products
in all price ranges.
The company now has all India Sales network comprising 40
dedicated diagnostic specialists. It also has more than 55 distributors all
over the country and the cold storage facilities for he products maintained at
Delhi and Mumbai.
|
Name
of the company |
SUYOG SALES AGENCY PRIVATE LIMITED |
|
Presented By |
JOINTLY COMPANY AND CHARGE HOLDER |
|
1) Date
and description of instrument creating the change |
Agreement
for cash credit and agreement for hypothecation of book debts both dated
02.04.1998 and together constituting a single charge. |
|
2) Amount
secured by the charge/amount owing on the securities of charge |
Rs. 1.000
Millions |
|
3) Short
particular of the property charged. If the property acquired is subject to
charge, date of the acquired of the property should be given |
All
Products, goods, movable property of any kind belonging to the company which
now or hereafter from time to time be brought in, stored or be in or about
the premises or Godown at Andheri [East] or any other godowns or in course of
transit from one Godown to another or wherever else the same may be. All
present create in respect of cash credit limit of Rs. 1.000 Millions |
|
4) Gist
of the terms and conditions and extent and operation of the charge. |
Security created
in respect of cash credit limit of Rs. 1.000 Millions Security
created by way of first charge and to cover principal together with interest,
charges costs, expenses etc. Interest
@ 4.5 % p.a. over bank’s PLr with a minimum of 18.5 % interest tax p.a. or
such other rate as decided by the bank from time to time. Margin at
such rates as stipulated by the bank from time to time. |
|
5) Name
and Address and description of the person entitled to the charge. |
Bank of
Punjab Fort Mumbai –
400023, Maharashtra, India |
|
6)
Date and brief description of
instrument modifying the charge |
|
|
7)
Particulars of modifications specifying the terms and conditions or the
extent of operations of the charge in which modification is made and the details
of the modification. |
|
Website Details Attached:
The spirit of enterprise knows no
frontiers as reflected by the growth of Suyog Diagnostics Private Limited since
its inception in 1996. Suyog's corporate beliefs of always striving on new
challenges, mastering new technologies and undertaking new projects, have laid
a strong foundation for a solid future. The team behind the success of this
organisation comprises of dedicated professionals who have been in the field of
diagnostics for the last 10 to 15 years.
SUYOG - A PROFILE
AN INTRODUCTION
The spirit of enterprise knows no
frontiers as reflected by the growth of Suyog Diagnostics Private Limited since
its inception in 1996. Suyog's corporate beliefs of always striving on new
challenges, mastering new technologies and undertaking new projects, have laid
a strong foundation for a solid future. The team behind the success of this
organisation comprises of dedicated professionals who have been in the field of
diagnostics for the last 10 to 15 years.
With a clear vision, existing
infrastructure and professional management, Suyog is confident of achieving the
target it has set for itself.
Their company has a proven track record
for its ability to deliver reliable and precision products that meets specific
user requirements at affordable prices. Their Company is the exclusive business
associate in India for the world-renowned companies, manufacturing
state-of-the-art medical equipment and most sensitive diagnostic kits.
They have built up an excellent
rapport with the medical professionals through a team of 42 marketing
professionals and well trained Medical Engineers and Product Executives who
ensure prompt and quality after sales services. Today, Suyog is well known to
the leading medical professionals in the field of Microbiology, Blood Banks,
Pathology, and Haematology and are the suppliers of HIV kits to NACO, Member of
the Health and Family welfare.
Their Company is looking into the
possibilities for participating in India's march towards providing better
medical facilities to its citizens. Suyog not only undertakes installation,
demonstration and preventive maintenance of supplied systems but also provide
training on use of ELISA system, Coagulation Analyzers, etc.
Their motto is to bring expertise
in the quality and accuracy of Diagnosis in India through their Partner
companies:
Services:
·
Selling efnits, Reagents
·
Testing of plant virus on
Elisa, PCR
·
AMC of equipment
·
Regent Rental Contract
SUYOG's Instruments:
Coagulation
Analyzer:
STA - R
(Fully Automated Walk Away Coagulation Analyzer)
STA -
Compact (Fully Automated Walk Away Coagulation Analyzer
STA - Compact CT (Fully
Automated Walk Away Coagulation Analyzer)
St art8 (8
- Channel Semi Automated Coagulation Analyzer)
St art4 (4
- Channel Semi Automated Coagulation Analyzer)
ELISA
Processor:
ETI - MAX
3000 (Fully Automated Microplate Processor with 4 Plate Capacity)
ETI - LAB
(Fully Automated Microplate Processor with 3 Plate Capacity)
ETI - STAR
(Fully Automated Microplate Processor with 2 Plate Capacity)
ELISA
Reader & Washer:
ETI System
Reader (Microplate Reader)
ETI System
Washer (Microplate Washer)
Western
Blot Processor:
Auto Blot
36 (Fully Automated Western Blot Processor)
Auto Scan 2.0 (Software for analysis and processing of western blot results
from test strip)
Platelet
Aggrigometer:
Laser 4xmk2
Aggregometer
Clients:
List of a few prime
government organizations where they have installed their systems and who have
included us in their list of approved suppliers:
- All
India Institute of Medical Science, New Delhi
- Amrita
Institute of Medical Sciences, Cochin
- Armed
Forces Transfusion Centre, New Delhi
- Baptist
Hospital, Bangalore
- Batra
Hospital, New Delhi
- Bombay
Hospital Trust, Mumbai
- Breach
Candy Hospital and Research Centre, Mumbai
- Cadila
Pharmaceuticals, Ahmedabad
- Central
Blood Bank, Calcutta
- Chennai
Medical College, Chennai
- Choithram
Hospital and Research Centre, Indore
- Christian
Medical College & Hospital, Ludhiana
- Christian
Medical College & Hospital, Vellore
- Dayanand
Medical College, Ludhiana
- Dept.
of Atomic Energy, Bombay
- Director
General Armed Forces Medical Services, New Delhi
- Director
of Health and Family Welfare, Punjab
- Escorts
Hospital, Faridabad
- Escorts
Hospital, New Delhi
- ESI
Hospital, New Delhi
- G.B.
Pant Hospital, New Delhi
- Ganga
Ram Hospital, New Delhi
- Govt.
Medical College & Hospital, Chandigarh
- Guru
Teg Bahadur Hospital, New Delhi
- Haffkine
Institute for Training and Research, Mumbai
- Holy
Family Hospital, New Delhi
- Indian
Immunologicals, Hyderabad.
- Indian
Institute of Sciences, Bangalore
- Indian
Red Cross Society, New Delhi
- Indira
Gandhi Medical College, Shimla
- Indraprastha
Apollo Hospital, Chennai
- Indraprastha
Apollo Hospital, Delhi
- Institute
of Blood Transfusion, Calcutta
- Jawaharlal
Nehru Institute of Post-Graduate of Medical Education, Pondicherry
- Lady
Hardinge Medical College and Hospital, New Delhi
- Lok
Nayak Jai Prakash Hospital, New Delhi
- M.G.M.Medical
College, Bombay
- M.L.N.Medical
College, Allahabad
- Maharaja
Agrasen Hospital, Delhi
- Manipal
Hospital, Bangalore
- Mata
Channan Devi Hospital, New Delhi
- Ministry
of Defence, Pune
- National
Institute of Biologicals, New Delhi
- National
Institute of Communicable Diseases, Delhi
- Nizam’s
Institute of Medical Science, Hyderabad
- Northern
Railway Hospital, New Delhi
- Northern
Railways, Baroda
- P.D.Hinduja
National Hospital, Bombay
- Pandit
B.D.Sharma Post Graduate Institute of Medical Science, Rohtak
- PGIMER,
Chandigarh
- PSG
Medical College, Coimbatore
- Ram
Manohar Lohia Hospital, New Delhi
- S.N.
Medical College, Jodhpur
- S.P.
Medical College, Bikaner
- Safdarjung
Hospital, New Delhi
- Sanjay
Gandhi Post Graduate Institute, Lucknow
- Santokaba
Durlabhji Memorial Hospital , Jaipur
- Sher-E-Kashmir
Institute of Medical Science, Soura, Srinagar
- Shri
Moolchand Kharatiram Hospital, New Delhi
- Singhania
Hospital & Medical Research, Bombay
- SMS
Hospital, Jaipur
- Sri
Chitra Tirunal Institute of Medical Sciences, Trivandrum.
- St
John`s Medical College and Hospital, Bangalore
- St.
Stephans Hospital, New Delhi
- Tata
Memorial Hospital, Bombay
- Tripura
Medical College, Vishakhapatnam.
- Tuberculosis
Research Centre, Tamil Nadu
- University
of Madras, Chennai
- Zonal
Blood Transfusion Centre, Jodhpur etc.
CMT REPORT [Corruption, Money
laundering & Terrorism]
The Public
Notice information has been collected from various sources including but not
limited to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION
ON DESIGNATED PARTY
No
records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court
Declaration :
No records exist to suggest that subject is or was the
subject of any formal or informal allegations, prosecutions or other official
proceeding for making any prohibited payments or other improper payments to
government officials for engaging in prohibited transactions or with designated
parties.
3] Asset
Declaration :
No
records exist to suggest that the property or assets of the subject are derived
from criminal conduct or a prohibited transaction.
4] Record
on Financial Crime :
Charges or conviction registered
against subject: None
5] Records
on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records
on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal
Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation
with Government :
No
record exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation
Package :
Our
market survey revealed that the amount of compensation sought by the subject is
fair and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on the subject.
CORPORATE GOVERNANCE
MIRA INFORM
as part of its Due Diligence do provide comments on Corporate Governance to
identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a
company’s management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject is
not known to have contravened any existing local laws, regulations or policies
that prohibit, restrict or otherwise affect the terms and conditions that could
be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.13 |
|
UK Pound |
1 |
Rs.86.40 |
|
Euro |
1 |
Rs.56.99 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP
CAPITAL |
1~10 |
5 |
|
OPERATING
SCALE |
1~10 |
4 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS
SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
4 |
|
--LIQUIDITY |
1~10 |
4 |
|
--LEVERAGE |
1~10 |
4 |
|
--RESERVES |
1~10 |
4 |
|
--CREDIT
LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT
POINTS |
|
|
|
--BANK
CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER
ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT
POINTS |
|
|
|
--SOLE
DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT
ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER
MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
40 |
This
score serves as a reference to assess SC’s credit risk and to set the amount of
credit to be extended. It is calculated from a composite of weighted scores
obtained from each of the major sections of this report. The assessed factors
and their relative weights (as indicated through %) are as follows:
Financial condition (40%) Ownership background
(20%) Payment record (10%)
Credit history (10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for
credit transaction. It has above average (strong) capability for payment of
interest and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy.
General unfavourable factors will not cause fatal effect. Satisfactory
capability for payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet
normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight
in credit consideration. Capability to overcome financial difficulties seems comparatively
below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and
principal sums in default or expected to be in default upon maturity |
Limited with full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be
exercised |
Credit not recommended |
|
NR |
In view of the lack of information, we have no basis upon
which to recommend credit dealings |
No Rating |
|